DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Iwata H, Tamura K, Doi T. et al.
Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing solid tumors: Long-term results of a large phase 1 study with multiple expansion cohorts.

J Clin Oncol 2018;
DOI: 10.1200/JCO.2018.1236.1215_suppl.2501.

Download Bibliographical Data

Search in: